PE
BIIB icon

Point72 Europe’s Biogen BIIB Stock Holding History

Point72 Europe’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$13.9M Buy
99,013
+3,333
+3% +$451K 0.68% 36
2025
Q2 		$12M Buy
95,680
+13,204
+16% +$1.65M 0.46% 52
2025
Q1 		$11.3M Buy
+82,476
New +$11.8M 0.77% 49

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Point72 Europe's BIIB Position: Q3 2025 in Review

Point72 Europe increased its Biogen (BIIB) stake by 3.5% in Q3 2025, buying an estimated $451K and bringing the position to 99,013 shares worth $13.9M. The position accounts for 0.68% of the portfolio, ranked #36.

Point72 Europe first reported a position in BIIB in Q1 2025 and has held it in 3 quarters since. 905 funds tracked by Wall St. Rank hold BIIB as of Q3 2025.

  • Point72 Europe held 99,013 shares of Biogen worth $13.9M as of Q3 2025.
  • Point72 Europe bought 3,333 Biogen shares in Q3 2025, an estimated $451K.
  • Biogen made up 0.68% of Point72 Europe's portfolio in Q3 2025, its #36 holding.
  • Point72 Europe first reported a position in Biogen in Q1 2025 and has held it in 3 quarters since.
  • 905 funds tracked by Wall St. Rank held Biogen as of Q3 2025.

Based on Point72 Europe's 13F filing for Q3 2025, filed 14 Nov 2025.